Register for our free email digests:
Latest From Getinge AB
Venus Medtech, the Chinese transcatheter aortic valve technology specialist, has made its second international acquisition as it pursues its strategy for global expansion in the TAVR market.
Getinge is looking for a new CEO after deciding to jettison Alex Myers from the helm, less than 18 months after he took up the top executive role.
Hemovent GMBH has developed a miniaturized extracorporeal membrane oxygenation system for bedside use in intensive care. The start-up says the footprint of its ECMO is just 10% the size of the smallest commercially available heart-lung machine, and the cost of the unit is 95% less than a standard ECMO device.
Derived from Strategic Transactions, Informa’s premium source for tracking life sciences deal activity, the Medical Device Deals Update column is a survey of recent medtech M&A, alliance, and financing activity. This month’s column covers deals announced November-December 2015.
- Implantable Devices
- Infection Control-Sterilization
Surgical Equipment & Devices
- Minimally or Less Invasive
- Therapeutic Areas
- Getinge Medical Systems
- Western Europe
- Parent & Subsidiaries
- Getinge AB
- Senior Management
Johan Malmquist, Pres. & CEO
Ulf Grunander, CFO
Michael Rieder, EVP, Sales & Mktg.
- Contact Info
Phone: (46) 10 335 0000
P.O. Box 8861 Göteborg, NY SE-402 72
You must sign in to use this functionality
All set! This article has been sent to firstname.lastname@example.org.
All fields are required. For multiple recipients, separate email addresses with a semicolon.